Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating arthralgia and myalgia

A technology of medicine for muscle and bone pain, applied in the field of medicine for the treatment of muscle and bone pain, can solve the problem of unsatisfactory effect and achieve clear curative effect and good safety

Inactive Publication Date: 2013-06-12
程爱军
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In order to solve these pains, people have carried out a lot of research, but the effect is not particularly ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0012] Experimental example 1 Treatment of bruises

[0013] A total of 40 cases were treated, including 20 males and 20 females, aged 23-75 years. The shortest duration is 2 hours and the longest is 2 days. Among them, there were 20 cases of knee medial and lateral collateral ligament injury, 11 cases of patellar ligament injury, and 9 cases of infrapatellar fat pad and meniscus injury.

[0014] With reference to "Diagnostic and Curative Criteria for Diseases and Syndromes of Traditional Chinese Medicine" (State Administration of Traditional Chinese Medicine. "Standards for Diagnosis and Curative Effects of Diseases and Syndromes of Traditional Chinese Medicine". Nanjing: Nanjing University Press, 1994, 198-201.) formulate treatment standards. Cured: the pain symptoms and signs completely disappeared, and the joint function recovered; markedly effective: the pain symptoms and signs basically disappeared, and the joint function was significantly improved; improved: the pain sy...

experiment example 2

[0017] The treatment of experimental example 2 arthritis

[0018] Among the 50 patients, there were 25 males and 25 females. The youngest age was 16 years old, the oldest age was 63 years old, and the average age was 36 years old. Rheumatoid factor was positive. "Criteria for Diagnosis and Curative Effect of Diseases and Syndromes of Traditional Chinese Medicine" (State Administration of Traditional Chinese Medicine. "Standards for Diagnosis and Curative Effects of Diseases and Syndromes of Traditional Chinese Medicine". Nanjing: Nanjing University Press, 1994, 52-53.) on the diagnostic criteria of Arthralgia Syndrome. Among them, there were 25 cases of wind-cold-damp arthralgia, and 25 cases of rheumatic-heat arthralgia.

[0019] Efficacy criteria: recovery: all symptoms and signs disappeared, laboratory examination showed normal erythrocyte sedimentation rate, normal C-reactive protein, and negative rheumatoid factor. Effective: Symptoms and signs basically disappeared, la...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for treating arthralgia and myalgia. The medicament is prepared from the following substances in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of chrysanthemum, 10-30 parts of golden-rod, 1-15 parts of albizia flower, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of tabasheer, 1-20 parts of morinda officinalis, 1-20 parts of white atractylodes rhizome, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of parts of kamuning, 10-20 parts of kaladana, 15-20 parts of herba inulae, 15-30 parts of herb of glabrous sarcandra, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of rhizoma atractylodis, 15-25 parts of rhododendron dauricum, 15-25 parts of angelica sinensis, 10-20 parts of chinese lantern-plant, 15-25 parts of lophatherum gracile, 20-30 parts of lindley eupatorium, 1-20 parts of wadalee-gum-tree and 10-25 parts of chinese azalea flower. All components of the medicament for treating the arthralgia and myalgia disclosed by the invention are natural materials; and the medicament is good in security, definite in curative effect, and suitable for large-scale clinical popularization.

Description

technical field [0001] The invention relates to the field of acupuncture and moxibustion, in particular to a medicament for treating muscle and bone pain. Background technique [0002] In daily life, people are often plagued by bone diseases, especially rheumatic numbness, arthritis, frozen shoulder pain, and lumbar muscle strain, muscle soreness, muscle pain, and bruises caused by these inflammations. In order to solve these pains, people have carried out a lot of research, but the effect is not particularly ideal. Contents of the invention [0003] The object of the present invention is to provide a medicament for treating musculoskeletal pain. [0004] In order to realize the object of the present invention, the present invention provides a kind of medicament for the treatment of muscle and bone pain, and it is made of the material of following weight ratio: Scrophulariaceae 5-10 parts, dried ginger 10-20 parts, cornus officinalis 20-30 parts , Platycodon 10-20, Copti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61P29/00A61P19/02
Inventor 程爱军
Owner 程爱军
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products